Assembly Bill A3820A

2019-2020 Legislative Session

Limits the initial prescription of a controlled substance for the alleviation of acute pain

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

2019-A3820 - Details

See Senate Version of this Bill:
S2053
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §3331, Pub Health L
Versions Introduced in Other Legislative Sessions:
2017-2018: A7741, S6256
2021-2022: A3221
2023-2024: A1133

2019-A3820 - Summary

Limits the initial prescription of a controlled substance for the alleviation of acute pain to a seven-day supply for users twenty years of age or older and to a three-day supply for users nineteen years of age or younger.

2019-A3820 - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   3820
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 31, 2019
                                ___________
 
 Introduced  by  M.  of  A.  McDONALD,  ORTIZ, MONTESANO, FRIEND, JAFFEE,
   JONES, BARRON,  LUPARDO,  D'URSO,  WALLACE,  SEAWRIGHT,  SANTABARBARA,
   STECK,  GALEF,  FAHY, CAHILL, BLANKENBUSH -- read once and referred to
   the Committee on Health
 
 AN ACT to amend the public health  law,  in  relation  to  limiting  the
   initial  prescription of a controlled substance for the alleviation of
   acute pain from a seven-day supply to a three-day supply
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Paragraph  (b)  of  subdivision  5 of section 3331 of the
 public health law, as added by section 1 of part C of chapter 71 of  the
 laws of 2016, is amended to read as follows:
   (b)  Notwithstanding  the provisions of paragraph (a) of this subdivi-
 sion, a practitioner, within the scope of his or her professional  opin-
 ion  or  discretion, may not prescribe more than a [seven-day] THREE-DAY
 supply of any schedule II, III, or IV opioid to an  ultimate  user  upon
 the  initial consultation or treatment of such user for acute pain. Upon
 any subsequent consultations for the same  pain,  the  practitioner  may
 issue,  in accordance with paragraph (a) of this subdivision, any appro-
 priate renewal, refill, or new prescription for the opioid or any  other
 drug.
   § 2. This act shall take effect immediately.
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD07450-01-9



              

co-Sponsors

2019-A3820A (ACTIVE) - Details

See Senate Version of this Bill:
S2053
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §3331, Pub Health L
Versions Introduced in Other Legislative Sessions:
2017-2018: A7741, S6256
2021-2022: A3221
2023-2024: A1133

2019-A3820A (ACTIVE) - Summary

Limits the initial prescription of a controlled substance for the alleviation of acute pain to a seven-day supply for users twenty years of age or older and to a three-day supply for users nineteen years of age or younger.

2019-A3820A (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  3820--A
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 31, 2019
                                ___________
 
 Introduced  by  M.  of  A.  McDONALD,  ORTIZ, MONTESANO, FRIEND, JAFFEE,
   JONES, BARRON,  LUPARDO,  D'URSO,  WALLACE,  SEAWRIGHT,  SANTABARBARA,
   STECK,  GALEF,  FAHY, CAHILL, BLANKENBUSH -- read once and referred to
   the Committee on Health -- committee discharged, bill amended, ordered
   reprinted as amended and recommitted to said committee

 AN ACT to amend the public health  law,  in  relation  to  limiting  the
   initial  prescription of a controlled substance for the alleviation of
   acute pain to a seven-day supply for users  twenty  years  of  age  or
   older  and  to  a  three-day supply for users nineteen years of age or
   younger
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Paragraph  (b)  of  subdivision  5 of section 3331 of the
 public health law, as added by section 1 of part C of chapter 71 of  the
 laws of 2016, is amended to read as follows:
   (b)  Notwithstanding  the provisions of paragraph (a) of this subdivi-
 sion, a practitioner, within the scope of his or her professional  opin-
 ion or discretion, may not prescribe more than a seven-day supply of any
 schedule  II,  III, or IV opioid to an ultimate user WHO IS TWENTY YEARS
 OF AGE OR OLDER, OR MORE THAN A THREE-DAY SUPPLY  OF  ANY  SCHEDULE  II,
 III,  OR  IV  OPIOID TO AN ULTIMATE USER WHO IS NINETEEN YEARS OF AGE OR
 YOUNGER upon the initial consultation or  treatment  of  such  user  for
 acute  pain.  Upon  any  subsequent consultations for the same pain, the
 practitioner may issue, in accordance with paragraph (a) of this  subdi-
 vision,  any  appropriate  renewal,  refill, or new prescription for the
 opioid or any other drug.
   § 2. This act shall take effect immediately.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD07450-02-9


              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.